ClinicalTrials.gg
WithdrawnNCT04561700Updated Jan 10, 2022

Nutritive Sucking Patterns in Premature Infants

An interventional study of Reporting of sucking patterns captured by Instrumented Bottle and Control in Premature, Light-For-Dates Without Mention of Fetal Malnutrition, Unspecified and Feeding Patterns, sponsored by University of Alabama at Birmingham. Withdrawn. Open to participants aged 7 Days to 60 Days. Per ClinicalTrials.gov, last updated 2022-01-10.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Supportive care

Why this study was withdrawn
Unfunded
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
7 Days to 60 Days
Sex
All
01

Study summary

In this pilot trial, the investigators will determine the feasibility of monitoring nutritive sucking patterns to facilitate the transition from tube to oral feeding in extremely-low-birth weight (ELBW) infants

Read the detailed description

In this parallel-group randomized controlled trial, ELBW infants (birthweight \< 1000 grams) will be randomly assigned in a 1:1 ratio to either weekly reporting on objective measurements of sucking activity during oral feeding (intervention group) or usual care without information on sucking activity (control group).

02

Conditions studied

  • Premature
  • Light-For-Dates Without Mention of Fetal Malnutrition, Unspecified
  • Feeding Patterns
03

In context

Premature Birth

2,550 studies on the registry are indexed under Premature Birth; 500 are open to participants now.

Browse Premature Birth studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,421 studies on the registry; 277 are open to participants now.

Of its 164 completed or terminated interventional studies of FDA-regulated products, 130 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Days to 60 Days
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Birthweight \< 1000 grams
  • Gestational age \< 32 weeks of gestation
  • Full enteral feeding established before or on postnatal day 21
  • Oral feeding initiated before or at 33 weeks of postmenstrual age

Exclusion criteria

Exclusion Criteria:

  • Major congenital/chromosomal anomalies
  • Patent ductus arteriosus causing significant cardiovascular symptoms
  • History of necrotizing enterocolitis stage 2 or greater
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Reporting of sucking patterns captured by Instrumented Bottle

    Weekly reporting on objective measurements of sucking activity during oral feeding

    Diagnostic Test: Reporting of sucking patterns captured by Instrumented Bottle

  • Sham comparator
    Control

    Weekly reporting on traditional measurements of sucking activity during oral feeding (no objective measurements reported)

    Diagnostic Test: Control

Interventions

  • Diagnostic testReporting of sucking patterns captured by Instrumented Bottle

    In the intervention group, data on nutritive sucking and feeding cues captured by the Instrumented Bottle will be made available to speech therapists to document the feeding session and provide written recommendations in their weekly report.

  • Diagnostic testControl

    In the control group, the information captured by the Instrumented Bottle will not be made available to speech therapists and therefore, will not be used to document a feeding session or provide weekly recommendations.

06

What researchers measure

Primary outcomes

  1. Time to independent oral feeding

    Time interval in days from introduction of oral feeding to full independent oral feeding

    Time frame: Birth to 120 days

Secondary outcomes

  1. Postnatal age at discharge

    Age in days at the time of hospital discharge

    Time frame: Birth to 120 days

  2. Length of hospital stay

    Total number of hospitalization days

    Time frame: Birth to 120 days

  3. Growth rate during the transition from tube to oral feeding

    Weekly weight gain in g/kg/day

    Time frame: Birth to 120 days

  4. Tube feeding events per day during the transition from tube to oral feeding.

    Daily count of tube feeding events

    Time frame: Birth to 120 days

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04561700
Responsible party
Ariel A. Salas (Assistant Professor, University of Alabama at Birmingham) — Principal investigator
First posted
Sep 24, 2020
Start date
Oct 2021 (estimated)
Primary completion
Jul 2022 (estimated)
Completion
Jun 2023 (estimated)
Last update
Jan 10, 2022

Study contacts

Ariel A. Salas, MD, MSPH
principal investigator · University of Alabama at Birmingham

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion